Line 468: |
Line 468: |
| | | | | |
| |- | | |- |
− | | Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health) | + | | Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy + Greg r |
| + | Conboy (Monash Health) |
| | | | | |
| | | | | |
Line 757: |
Line 758: |
| | | | | |
| |- | | |- |
− | | B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease||Afia Hasnain + Yassmine Akkari | + | | B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease||Afia Hasnain (trainee) + Yassmine Akkari |
| | | | | |
| | | | | |
Line 1,171: |
Line 1,172: |
| | | | | |
| |- | | |- |
− | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera | + | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee (trainee)/Fabiola Quintero-Rivera |
| |3/9/21 | | |3/9/21 |
| | | | | |